Methods for reducing non-specific antibody binding in enzyme-linked immunosorbent assays.

Area of Science:

• Immunology
• Biochemistry
• Assay Development

Background:

• Enzyme-linked immunosorbent assays (ELISAs) are widely used for detecting specific antibodies.
• Non-specific binding (NSB) can interfere with assay sensitivity and specificity.
• Traditional blocking agents like Tween 20 may not always effectively prevent NSB.

Purpose of the Study:

• To investigate the efficacy of casein as a blocking agent in ELISAs.
• To compare casein with other blocking agents like bovine serum albumin and gelatin.
• To optimize conditions for using casein to reduce NSB in antibody binding assays.

Main Methods:

• Enzyme-linked immunosorbent assays (ELISAs) were performed using rabbit and human antibodies.
• Various blocking agents, including Tween 20, bovine serum albumin, gelatin, and casein, were tested.
• Assays involved studying antibody binding to liver membrane fractions and liver-specific lipoprotein.
• Optimization involved varying buffer compositions and including Thimerosal.

Main Results:

• High non-specific binding was observed with Tween 20 as a blocking agent.
• Casein effectively abolished non-specific binding of antibodies in both rabbit and human serum assays.
• Casein proved more effective than bovine serum albumin or gelatin.
• Specific conditions involving casein and Thimerosal were identified for optimal blocking with human sera.

Conclusions:

• Casein is a superior blocking agent for reducing non-specific binding in ELISAs compared to Tween 20.
• The developed casein-based blocking buffers may enhance the reliability of solid-phase immunoassays.
• These findings offer a valuable improvement for researchers encountering high NSB in their assays.